GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (FRA:DV3R) » Definitions » Cyclically Adjusted PB Ratio

Delcath Systems (FRA:DV3R) Cyclically Adjusted PB Ratio : (As of May. 18, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Delcath Systems Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Delcath Systems Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Delcath Systems's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delcath Systems Cyclically Adjusted PB Ratio Chart

Delcath Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Delcath Systems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Delcath Systems's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Delcath Systems's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delcath Systems's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Delcath Systems's Cyclically Adjusted PB Ratio falls into.



Delcath Systems Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Delcath Systems's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Delcath Systems's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.529/131.7762*131.7762
=0.529

Current CPI (Mar. 2024) = 131.7762.

Delcath Systems Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 -776.000 104.136 -981.973
201712 1,790.625 104.011 2,268.621
201803 -3,929.688 105.290 -4,918.243
201806 -8,424.812 106.317 -10,442.279
201809 -512.162 106.507 -633.676
201812 -892.052 105.998 -1,108.996
201903 -1,020.019 107.251 -1,253.274
201906 -1,007.274 108.070 -1,228.235
201909 -654.403 108.329 -796.042
201912 -85.274 108.420 -103.644
202003 -99.560 108.902 -120.473
202006 1.942 108.767 2.353
202009 0.689 109.815 0.827
202012 3.027 109.897 3.630
202103 2.688 111.754 3.170
202106 1.712 114.631 1.968
202109 1.355 115.734 1.543
202112 1.338 117.630 1.499
202203 0.600 121.301 0.652
202206 -0.340 125.017 -0.358
202209 -0.616 125.227 -0.648
202212 -0.551 125.222 -0.580
202303 -1.211 127.348 -1.253
202306 -0.015 128.729 -0.015
202309 1.176 129.860 1.193
202312 0.636 129.419 0.648
202403 0.529 131.776 0.529

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Delcath Systems  (FRA:DV3R) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Delcath Systems Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Delcath Systems's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Delcath Systems (FRA:DV3R) Business Description

Traded in Other Exchanges
Address
1633 Broadway, Suite 22C, New York, NY, USA, 10019
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Delcath Systems (FRA:DV3R) Headlines

No Headlines